ClinicalTrials.gg
Not yet recruitingNCT06493396Updated Oct 20, 2026

Effect of Opioid-free Anesthesia on Sleep Quality, Cognitive Function and Recovery Quality After General Anesthesia in Elderly Patients

An interventional study of Opioid-free Analgesics and Opioid group in Opioid-Free Anesthesia, POCD and Recovery Quality, sponsored by Beijing Friendship Hospital. Not yet recruiting. Open to participants aged 60 Years and older. Per ClinicalTrials.gov, last updated 2026-10-20.

Sponsored by Beijing Friendship Hospital · Not applicable, Interventional, and Treatment

How we know

Updated Oct 20, 2026Start date movedPrimary completion moved+1 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
88
Allocation
Randomized
Ages
60 Years and older
Sex
All
01

Study summary

Postoperative cognitive dysfunction (POCD)is a common well disorder of the central nervous system after surgery, mainly manifested by impaired memory, spirit, language ability or other aspects of brain function. POCD, which often occurs in elderly patients over 65 years, The recent phase is recommended to be changed to perioperative neurocognitive impairment ( PND), The PND is used to describe the cognitive function changes that occur before and within 1 year after surgery, Based on the time of disease onset, It can be divided into neurocognitive impairment existing before surgery, postoperative delusion (POD) occurring hours to days after surgery, neurocognitive recovery delay (DNR) within 30 days after surgery, and postoperative neurocognitive impairment occurring weeks to months after surgery (POND). With the acceleration of the aging process of Chinese social population, the frequency of surgical treatment for elderly inpatients has also increased, and the elderly patients have postoperative sleep disorders, and POCD is relatively common. Surgical patients after surgical trauma, the body inflammation, sympathetic excitation and endocrine disorders, make postoperative sleep structure or pattern change, often lead to postoperative sleep disorders (PSD) , the main performance for patients with postoperative complaint difficult to enter and maintain sleep, frequent nightmares, total sleep quantity and quality reduction, etc. PSD is not only the most common manifestation of postoperative brain dysfunction, but also an important risk factor for inducing postoperative fatigue, postoperative hyperalgesia, metabolic dysfunction, and cardiovascular and cerebrovascular diseases. Moreover, it is considered to promote the development of postoperative delusion. At present, the common mode of general anesthesia is still mainly opioids, and opioids are an important part of general anesthesia and perioperative analgesia. Perioperative use of opioids is not only associated with adverse effects such as postoperative nausea and vomiting, excessive sedation, and ileus, but also leads to the occurrence of postoperative hypoxemia, hyperalgesia and postoperative chronic pain, and cognitive impairment. Therefore, the Association of Accelerated Rehabilitation Surgery indicates that the use of a multimodal analgesic regimen during the perioperative period reduces pain and reduces opioid-related adverse effects, and that opioid-free anesthesia ( OFA) is used in clinical work. At present, most clinical studies of OFA focus on adults aged 18-65 or 18 years old, and few studies focus OFA solely on the elderly population to observe its application effect. Therefore, it is necessary to conduct clinical studies to observe postoperative recovery in elderly patients with different types of anesthetics, investigate the incidence and severity of POCD, and determine the efficacy and safety of each anesthetic agent.

02

Conditions studied

  • Opioid-Free Anesthesia
  • POCD
  • Recovery Quality
  • Sleep Quality
03

In context

Sleep Initiation and Maintenance Disorders

2,738 studies on the registry are indexed under Sleep Initiation and Maintenance Disorders; 735 are open to participants now.

This study's planned enrollment of 88 is above the median of 68 across 2,363 interventional studies indexed under Sleep Initiation and Maintenance Disorders.

Browse Sleep Initiation and Maintenance Disorders studies →

Lead sponsor

Beijing Friendship Hospital is the lead sponsor of 217 studies on the registry; 94 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
60 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Elderly patients to undergo elective non-cardiac surgery

    • I or III;

      • volunteered in this trial and signed ;

        • age 60 years;

          • 18-30kg / m2.

Exclusion criteria

Exclusion Criteria:

  • Chronic pain;

    • severe liver dysfunction (total 2 mg dl-1);

      • severe renal dysfunction ( 60ml min-1 1.73m-2);

        • preoperative heart rate \<50 beats / min, sick sinus syndrome, severe heart block;

          • dementia or significant neurological disease (such as stroke, epilepsy, intracranial tumor, Parkinson disease, etc);

            • history of alcohol or drug abuse;

              • preoperative or PSQI score 7 or sleep disturbance;

                • Cannot cooperate with the scale survey

                  • Allergic to the trial drug
Terms in these criteria, in plain language(5)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

Bilirubin

A yellow substance made when red blood cells are broken down, which the liver clears. A high level can mean a problem with the liver or the bile ducts.

Criteria often allow more for people with Gilbert’s syndrome, a harmless inherited condition that raises bilirubin.

GFR and eGFR (kidney filtering)

GFR (glomerular filtration rate) is how much blood the kidneys filter each minute. It is usually estimated from a blood test — eGFR, by formulas such as CKD-EPI or MDRD — and some studies ask for it to be measured directly instead. Usually given in mL/min/1.73 m².

Check the method, the units and the minimum the study states. A value of 90 or above is in the normal-or-high range, but kidney damage can show in other tests too.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
88 participants (estimated)

Study arms

  • Experimental
    Opioid-free group

    Drug: Opioid-free Analgesics

  • Active comparator
    Opioid group

    Drug: Opioid group

Interventions

  • DrugOpioid-free Analgesics

    opioid free group: After infusion of a loading dose of dexmedetomidine, intravenous midazolam 2mg, propofol 2mg kg-1, esketamine 0.5 mg kg-1, rocuronium 0.6-1mg kg-1, and 3min after endotracheal intubation. Intravenous continuous infusion of propofol, esketamine and dexmedetomidine hydrochloride mixture (esketamine 50mg + dexmedetomidine hydrochloride 150 ug + 0.9% saline 50ml in the same 50ml syringe) 0.1ml kg-1 h-1-0.2 ml kg-1 h-1 (equivalent to esketamine 0.1-0.2mg kg-1 h-1; Dexmedetomidine hydrochloride 0.3-0.6 μ g kg-1 h-1) maintains a BIS value between 40-60, 10-20mg / time was added as appropriate.

  • DrugOpioidsStudies of OpioidsOpioids pageHow we knowJudged by ClinicalTrials.gg, not part of the registry record.

    Intravenous midazolam 2mg, propofol 2mg kg-1, sufentanyl 0.3-0.5 μ g kg-1, rocuronium 0.6-1mg kg-1,3min before endotracheal intubation. After successful endotracheal intubation, continuous intravenous infusion of propofol and remifentanil was started to maintain BIS values between 40-60, and rocuronium 10-20mg / time as appropriate. After the start of surgery, 10-20 μ g of sufentanil was added according to blood pressure and heart rate. At the end of the operation, 5mg and 50mg were injected before the end of the operation, and propofol and remifentanil were stopped at the end of the operation

06

What researchers measure

Primary outcomes

  1. 15-item recovery quality scale score 24 hours before surgery

    The QoR-15 scale is a global measure of postoperative recovery, with scores ranging from 0 (extremely poor QoR) to 150 (excellent QoR). QoR-15 has become the most widely reported indicator for the evaluation of postoperative life treatment in patients. Using wherever possible QoR-15 item scores on postoperative day 3, QoR-15 with very good validity, and good reliability, responsiveness and clinical acceptability, these data suggest that QoR-15 is an excellent patient-centered measure of postoperative QoR. Patient Acceptable symptom status describes the lowest absolute score considered by the patient to represent a healthy or good status health scale. A QoR-15 score of 118 or more indicates a good postoperative recovery

    Time frame: 24 hours before surgery

  2. 15-item recovery quality scale score 24 hours after surgery

    The QoR-15 scale is a global measure of postoperative recovery, with scores ranging from 0 (extremely poor QoR) to 150 (excellent QoR). QoR-15 has become the most widely reported indicator for the evaluation of postoperative life treatment in patients. Using wherever possible QoR-15 item scores on postoperative day 3, QoR-15 with very good validity, and good reliability, responsiveness and clinical acceptability, these data suggest that QoR-15 is an excellent patient-centered measure of postoperative QoR. Patient Acceptable symptom status describes the lowest absolute score considered by the patient to represent a healthy or good status health scale. A QoR-15 score of 118 or more indicates a good postoperative recovery

    Time frame: 24 hours after surgery

  3. 15-item recovery quality scale score 48 hours after surgery

    The QoR-15 scale is a global measure of postoperative recovery, with scores ranging from 0 (extremely poor QoR) to 150 (excellent QoR). QoR-15 has become the most widely reported indicator for the evaluation of postoperative life treatment in patients. Using wherever possible QoR-15 item scores on postoperative day 3, QoR-15 with very good validity, and good reliability, responsiveness and clinical acceptability, these data suggest that QoR-15 is an excellent patient-centered measure of postoperative QoR. Patient Acceptable symptom status describes the lowest absolute score considered by the patient to represent a healthy or good status health scale. A QoR-15 score of 118 or more indicates a good postoperative recovery

    Time frame: 48 hours after surgery

Secondary outcomes

  1. Pittsburgh Sleep Quality Index,PSQI

    The PSQI scale consists of seven aspects, including time to sleep, hypnotic drugs, sleep time, daytime dysfunction, sleep quality, sleep efficiency, and sleep disorders, with a total score of 0 to 21, which is generally considered in China Score 7 means the presence of sleep disturbance, the higher the score indicates more severe sleep disturbance\]; due to PSQI The simplicity of the scale has good reliability and validity, and the results of polysomnography and EEG exist larger Guan Xing, which has become the most widely used scale in sleep research at home and abroad

    Time frame: one night before surgery

  2. Pittsburgh Sleep Quality Index,PSQI

    The PSQI scale consists of seven aspects, including time to sleep, hypnotic drugs, sleep time, daytime dysfunction, sleep quality, sleep efficiency, and sleep disorders, with a total score of 0 to 21, which is generally considered in China Score 7 means the presence of sleep disturbance, the higher the score indicates more severe sleep disturbance\]; due to PSQI The simplicity of the scale has good reliability and validity, and the results of polysomnography and EEG exist larger Guan Xing, which has become the most widely used scale in sleep research at home and abroad

    Time frame: first night after surgery

  3. Pittsburgh Sleep Quality Index,PSQI

    The PSQI scale consists of seven aspects, including time to sleep, hypnotic drugs, sleep time, daytime dysfunction, sleep quality, sleep efficiency, and sleep disorders, with a total score of 0 to 21, which is generally considered in China Score 7 means the presence of sleep disturbance, the higher the score indicates more severe sleep disturbance\]; due to PSQI The simplicity of the scale has good reliability and validity, and the results of polysomnography and EEG exist larger Guan Xing, which has become the most widely used scale in sleep research at home and abroad

    Time frame: the second night after surgery

  4. Pittsburgh Sleep Quality Index,PSQI

    The PSQI scale consists of seven aspects, including time to sleep, hypnotic drugs, sleep time, daytime dysfunction, sleep quality, sleep efficiency, and sleep disorders, with a total score of 0 to 21, which is generally considered in China Score 7 means the presence of sleep disturbance, the higher the score indicates more severe sleep disturbance\]; due to PSQI The simplicity of the scale has good reliability and validity, and the results of polysomnography and EEG exist larger Guan Xing, which has become the most widely used scale in sleep research at home and abroad

    Time frame: one week after surgery

  5. Rhodes Index of Nausea and Vomiting

    Rhodes Index of Nausea, Vomiting, and Retching, an 8-item questionnaire, to measure the incidence and severity of nausea, vomiting, and retching At each timepoint, a total Rhodes score was calculated from the sum of the 8 RINVR questions. Total Rhodes scores were compared at 6 different timepoints as well as overall across all 6 time points. record Nausea and vomiting, the Rhodes index score. Score 0: No symptoms of nausea, vomiting or retching * 1-8 points: Mild symptoms * 9-16 points: Moderate symptoms * 17-24 points: Severe symptoms * 25 points and above: Extremely severe symptoms, where the patient's daily activities and eating are completely disrupted

    Time frame: one day before surgery

  6. Rhodes Index of Nausea and Vomiting

    Rhodes Index of Nausea, Vomiting, and Retching, an 8-item questionnaire, to measure the incidence and severity of nausea, vomiting, and retching At each timepoint, a total Rhodes score was calculated from the sum of the 8 RINVR questions. Total Rhodes scores were compared at 6 different timepoints as well as overall across all 6 time points. record Nausea and vomiting, the Rhodes index score. Score 0: No symptoms of nausea, vomiting or retching * 1-8 points: Mild symptoms * 9-16 points: Moderate symptoms * 17-24 points: Severe symptoms * 25 points and above: Extremely severe symptoms, where the patient's daily activities and eating are completely disrupted

    Time frame: 6,24,48 hours after surgery

  7. Ramsay score

    Total score: 1 to 6,1 indicates insufficient sedation and restlessness; 2 indicates quiet and cooperation; 3 indicates drowsiness and response to commands; 4 indicates shallow sleep and quick response to strong acoustic stimulation; 5 means slow to sleep and response to strong acoustic stimulation; 6 indicates too deep calm and difficult to wake up Score 7 means the presence of sleep disturbance, the higher the score indicates more severe sleep disturbance\]; due to PSQI The simplicity of the scale has good reliability and validity, and the results of polysomnography and EEG are large

    Time frame: 6, 24, 48 hours after surgery

  8. visual analgesia score

    The total score is 0 to 10,0 indicates no pain, and 10 indicates the most severe play ache

    Time frame: 6, 24, 48 hours after surgery

  9. The Mini-Cog cognitive score

    0 points: 3 words can not remember one, as dementia. 1\~2 points: can remember 1\~2 of 3 words, correct drawing clock test (CDT), normal cognitive function; incorrect CDT, and cognitive function deficit. 3 points: can remember 3 words, not fixed as dementia

    Time frame: first night before surgery

  10. The Mini-Cog cognitive score

    0 points: 3 words can not remember one, as dementia. 1\~2 points: can remember 1\~2 of 3 words, correct drawing clock test (CDT), normal cognitive function; incorrect CDT, and cognitive function deficit. 3 points: can remember 3 words, not fixed as dementia

    Time frame: first day,second day and one week after surgery

  11. Number of salvage analgesia used within 48 h after surgery

    record number of salvage analgesia used within 48 h after surgery

    Time frame: 48 h after surgery

07

Study locations

No study locations are listed for this record.

08

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Oct 2027; primary completion for Oct 2028, 12 months later.

Of 1,219 non-industry interventional studies with no phase under Sleep Initiation and Maintenance Disorders, half reached primary completion within 15 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 35. This study's planned 12 months is below that.

Counting every sponsor, half of 1,297 studies reached it within 15 months; a quarter within 6 and three quarters within 34.

Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 20, 2026: start Aug 2024 → Oct 2027, primary completion Aug 2025 → Oct 2028 and completion Aug 2025 → Oct 2028.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Jul 2, 2024
First posted
Jul 10, 2024
StartEst.
Oct 1, 2027was Aug 2024
Primary completionEst.
Oct 31, 2028was Aug 2025
CompletionEst.
Oct 31, 2028was Aug 2025
Last update
Oct 20, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Start date
Aug 1, 2024→Oct 1, 2027
Oct 20, 2026
Primary completion
Aug 31, 2025→Oct 31, 2028
Oct 20, 2026
Study completion
Aug 31, 2025→Oct 31, 2028
Oct 20, 2026
Secondary outcomes
2 description edited
What changed in the outcomes
  • DescriptionRhodes Index of Nausea and Vomiting: how it is measured was reworded
  • DescriptionRhodes Index of Nausea and Vomiting#2: how it is measured was reworded
Oct 20, 2026
Show all 1 update
  1. Oct 20, 2026
    Start date Aug 1, 2024→Oct 1, 2027
    Primary completion Aug 31, 2025→Oct 31, 2028
    Study completion Aug 31, 2025→Oct 31, 2028
    Secondary outcomes 2 description edited
    What changed in the outcomes
    • DescriptionRhodes Index of Nausea and Vomiting: how it is measured was reworded
    • DescriptionRhodes Index of Nausea and Vomiting#2: how it is measured was reworded
    + 2 other changes: verification date and index terms

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT06493396
Responsible party
Bijia Song (principal investigator, Beijing Friendship Hospital) — Principal investigator
First posted
Jul 10, 2024
Start date
Oct 1, 2027 (estimated)
Primary completion
Oct 31, 2028 (estimated)
Completion
Oct 31, 2028 (estimated)
Last update
Oct 20, 2026

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion